Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, ...
Encapsulated cross-section methods commence by mounting a cross-sectional sample into an epoxy or acrylic mold compound, conventionally around 1 inch in diameter, and surrounding the selected device, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback